Mark A Rubin Selected Research

Mark A Rubin Research Topics

Disease

215	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 03/2002
204	Neoplasms (Cancer) 06/2022 - 03/2002
34	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2002
20	Disease Progression 01/2022 - 05/2003
17	Adenocarcinoma 10/2022 - 05/2002
14	Carcinoma (Carcinomatosis) 10/2022 - 01/2003
11	Carcinogenesis 02/2016 - 08/2002
10	Prostatic Intraepithelial Neoplasia 10/2022 - 04/2002
8	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2003
7	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 07/2011 - 05/2002
6	Renal Cell Carcinoma (Grawitz Tumor) 10/2022 - 07/2002
6	Lymphatic Metastasis 11/2013 - 09/2006
5	Inflammation (Inflammations) 01/2016 - 03/2004
5	Margins of Excision 05/2013 - 01/2004
4	Melanoma (Melanoma, Malignant) 07/2010 - 07/2002
3	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2022 - 07/2007
3	Genomic Instability 01/2020 - 08/2008
3	Lymphoma (Lymphomas) 12/2018 - 07/2002
3	Retinoblastoma (Glioblastoma, Retinal) 01/2018 - 12/2006
3	Leukemia 09/2017 - 09/2009
3	Seminoma 08/2005 - 11/2002
2	Ductal Carcinoma 10/2022 - 01/2003
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 06/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 09/2002
2	Colonic Neoplasms (Colon Cancer) 01/2017 - 08/2002
2	Hypersensitivity (Allergy) 01/2017 - 07/2015
2	Genetic Translocation (Chromosomal Translocation) 11/2013 - 08/2011

Drug/Important Bio-Agent (IBA)

72	Proteins (Proteins, Gene)FDA Link 06/2022 - 03/2002
46	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2002
40	AndrogensIBA 10/2022 - 06/2004
33	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 09/2005
33	Prostate-Specific Antigen (Semenogelase)IBA 01/2018 - 03/2002
32	Hormones (Hormone)IBA 01/2021 - 09/2002
30	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 04/2002
24	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2002
22	Transcription Factors (Transcription Factor)IBA 01/2021 - 03/2007
16	Messenger RNA (mRNA)IBA 01/2021 - 04/2002
16	Biological ProductsIBA 12/2020 - 01/2006
12	Complementary DNA (cDNA)IBA 06/2013 - 08/2002
9	alpha-methylacyl-CoA racemaseIBA 06/2005 - 07/2002
8	Proto-Oncogene Proteins c-etsIBA 02/2013 - 10/2005
7	Pharmaceutical PreparationsIBA 01/2022 - 04/2008
7	Kazal Pancreatic Trypsin InhibitorIBA 01/2022 - 06/2008
7	ChromatinIBA 01/2019 - 07/2010
7	AntigensIBA 01/2016 - 05/2002
6	Serine Proteases (Serine Protease)IBA 11/2014 - 06/2008
6	OligonucleotidesIBA 11/2011 - 08/2002
6	LigandsIBA 05/2009 - 10/2004
5	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2021 - 04/2013
5	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2017
5	Formaldehyde (Formol)FDA Link 01/2018 - 05/2007
5	ParaffinIBA 11/2013 - 05/2007
5	Tumor Biomarkers (Tumor Markers)IBA 11/2013 - 07/2002
5	Keratins (Keratin)IBA 10/2013 - 09/2002
5	Monoclonal AntibodiesIBA 07/2010 - 05/2002
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 05/2013
4	TensinsIBA 01/2022 - 05/2013
4	Protein Isoforms (Isoforms)IBA 01/2017 - 02/2005
4	Cadherins (E-Cadherin)IBA 12/2003 - 01/2003
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 10/2015
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 06/2015
3	UbiquitinIBA 01/2021 - 10/2014
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021 - 04/2013
3	NucleotidesIBA 12/2020 - 02/2016
3	Aurora Kinase AIBA 01/2019 - 01/2013
3	abirateroneIBA 11/2018 - 01/2017
3	enzalutamideIBA 01/2018 - 01/2017
3	Long Noncoding RNAIBA 01/2018 - 03/2014
3	PlatinumIBA 01/2017 - 06/2014
3	Peptides (Polypeptides)IBA 10/2014 - 09/2005
3	Capsules (Microcapsules)IBA 03/2012 - 01/2005
3	Coenzyme A (CoA)IBA 02/2012 - 04/2002
3	EnzymesIBA 02/2012 - 03/2004
3	Racemases and Epimerases (Epimerases and Racemases)IBA 02/2012 - 04/2002
3	5' Untranslated Regions (5' UTR)IBA 08/2007 - 10/2005
3	beta CateninIBA 02/2006 - 05/2002
3	Imatinib Mesylate (Gleevec)FDA Link 01/2006 - 09/2004
3	Finasteride (Propecia)FDA LinkGeneric 11/2005 - 10/2003
3	Fatty Acids (Saturated Fatty Acids)IBA 06/2005 - 03/2004
3	AntibodiesIBA 05/2003 - 05/2002
2	SolutionsIBA 06/2022 - 01/2009
2	Cell-Free Nucleic AcidsIBA 06/2022 - 01/2018
2	5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA 01/2022 - 03/2012
2	Ligases (Synthetase)IBA 01/2021 - 01/2018
2	Adenosine Diphosphate (ADP)IBA 01/2020 - 10/2015
2	Phosphotransferases (Kinase)IBA 01/2019 - 10/2007
2	DesminIBA 01/2018 - 12/2016
2	Androgen Antagonists (Antiandrogens)IBA 01/2017 - 05/2009
2	Estrogen ReceptorsIBA 12/2016 - 07/2009
2	AutoantibodiesIBA 01/2016 - 09/2005
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 09/2015 - 03/2014
2	Docetaxel (Taxotere)FDA Link 11/2014 - 02/2005

Therapy/Procedure

67	Therapeutics 10/2022 - 08/2002
35	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 03/2002
30	Castration 01/2022 - 12/2010
13	Precision Medicine 01/2022 - 02/2015
10	Drug Therapy (Chemotherapy) 05/2021 - 09/2004
5	Radiotherapy 04/2014 - 10/2002
4	Aftercare (After-Treatment) 01/2022 - 06/2008
3	Lasers (Laser) 09/2007 - 03/2006